Soligenix, Inc.

SNGX • NASDAQ • Stock Fundamentals

Soligenix, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher J. Schaber, with a market cap of $6.4M.

Market Cap$6.4M

Employees15.0

CEOChristopher J. Schaber

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 8, 2026 · 1 month 6 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Soligenix, Inc.

Soligenix, Inc. (SNGX) has a market capitalization of $6.4M and trades on NASDAQ.

Soligenix, Inc. has approximately 15 employees.